① The core product of this technological innovation is its independently developed artificial intelligence multimodal brain-computer interface platform. This platform integrates non-invasive brain-computer interfaces, motion imagination paradigms, virtual reality technology, and AI algorithms to achieve a technical chain for collecting, decoding, and providing feedback on human body multimodal signals; ② Currently, the brain-computer interface market features an industrial landscape where multiple technological approaches compete simultaneously.

On September 7, 2026, Shuli Innovation (Shanghai) Intelligent Technology Co., Ltd. officially launched its IPO process, becoming the third leading company in the brain-computer interface sector to enter the IPO stage after Borui Kang and Qiangnao Technology. Founded in 2015, the company has a registered capital of 100 million yuan and holds national-level “small giant” qualifications for specialized, innovative, and unique technologies. Its headquarters are located in Shanghai. Its core product is an independently developed artificial intelligence multi-modal brain-computer interface platform, which integrates non-invasive brain-computer interfaces, motion imagery paradigms, virtual reality technology, and AI algorithms to achieve a complete technical chain from human body signal acquisition, decoding to feedback. This product has been applied in three clinical fields: central nervous system injuries, consciousness cognitive disorders, and neurodevelopmental disorders. This IPO was advised by Huatai United Securities as the advisory firm, Beijing Guofeng Law Firm served as the legal advisor, and Xinyong Zhonghe Accounting Firm was responsible for the audit. Currently, the brain-computer interface sector features an industrial structure with multiple technical routes competing simultaneously.